The Viral Protein Poly(A) Polymerase Catalytic Subunit Interacts with Guanylate-Binding Proteins 2 to Antagonize the Antiviral Ability of Targeting Ectromelia Virus
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242115750 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Zhenzhen Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Animal Disease Control and Prevention, Ministry of Agriculture Key Laboratory of Veterinary Public Health, Lanzhou Veterinar…. Hauptthemen laut MEDLINE: Ectromelia virus, Ectromelia, Infectious. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovation Program of Chinese Academy of Agricultural Sciences, Innovation Program of the Chinese Academy of Agricultural Sciences.
Abstract (Originalsprache)
The recent spread of the monkeypox virus among humans has heightened concerns regarding orthopoxvirus infections. Consequently, conducting a comprehensive study on the immunobiology of the monkeypox virus is imperative for the development of effective therapeutics. Ectromelia virus (ECTV) closely resembles the genetic and disease characteristics of monkeypox virus, making it a valuable research tool for studying orthopoxvirus–host interactions. Guanylate-binding proteins (GBPs), highly expressed interferon-stimulated genes (ISGs), have antagonistic effects against various intracellular pathogenic microorganisms. Our previous research has shown that GBP2 has a mild but statistically significant inhibitory effect on ECTV infection. The presence of a significant number of molecules in the poxvirus genome that encode the host immune response raises questions about whether it also includes proteins that counteract the antiviral activity of GBP2. Using IP/MS and co-IP technology, we discovered that the poly(A) polymerase catalytic subunit (PAPL) protein of ECTV is a viral regulatory molecule that interacts with GBP2. Further studies have shown that PAPL antagonizes the antiviral activity of GBP2 by reducing its protein levels. Knocking out the PAPL gene of ECTV with the CRISPR/Cas9 system significantly diminishes the replication ability of the virus, indicating the indispensable role of PAPL in the replication process of ECTV. In conclusion, our study presents preliminary evidence supporting the significance of PAPL as a virulence factor that can interact with GBP2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Animal Disease Control and Prevention, Ministry of Agriculture Key Laboratory of Veterinary Public Health, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzho…
- School of Public Health, Lanzhou University, Lanzhou 730000, China.
Förderung
- Innovation Program of Chinese Academy of Agricultural Sciences
- Innovation Program of the Chinese Academy of Agricultural Sciences
Zitieren
APA
Gao, Z., He, X., Chen, G., Fang, Y., Meng, Z., Tian, H., Zhang, H., & Jing, Z. (2023). The Viral Protein Poly(A) Polymerase Catalytic Subunit Interacts with Guanylate-Binding Proteins 2 to Antagonize the Antiviral Ability of Targeting Ectromelia Virus. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115750
Vancouver
Gao Z, He X, Chen G, Fang Y, Meng Z, Tian H, et al. The Viral Protein Poly(A) Polymerase Catalytic Subunit Interacts with Guanylate-Binding Proteins 2 to Antagonize the Antiviral Ability of Targeting Ectromelia Virus. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115750
BibTeX
@article{Gao2023,
author = {Gao, Zhenzhen and He, Xiaobing and Chen, Guohua and Fang, Yongxiang and Meng, Zejing and Tian, Huihui and Zhang, Hui and Jing, Zhizhong},
title = {The Viral Protein Poly(A) Polymerase Catalytic Subunit Interacts with Guanylate-Binding Proteins 2 to Antagonize the Antiviral Ability of Targeting Ectromelia Virus},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242115750}
}
EUVIMED